Effects of E2 on the IDO1-mediated metabolic KYN pathway in OVX female mice

Xi Jiang1, Xuefeng Yu2, Shuran Hu3

  • 1Department of Pharmacy, Zhejiang University Mingzhou Hospital, Ningbo, China.

Insights

17β-estradiol (E2) treatment improved depressive-like behaviors in ovariectomy (OVX) mice by reducing inflammation and oxidative stress via the estrogen receptor beta (ERβ). This highlights ERβ

Area of Science:

  • Neuroscience
  • Endocrinology
  • Pharmacology

Background:

  • Ovariectomy (OVX) in mice leads to depressive-like behaviors, potentially linked to hormonal changes and neuroinflammation.
  • 17β-estradiol (E2) is a key hormone with known effects on mood and brain function.
  • Estrogen receptors (ERs), particularly ERβ, are implicated in mediating E2's effects in the central nervous system.

Purpose of the Study:

  • To investigate the role of 17β-estradiol (E2) and its receptor, estrogen receptor beta (ERβ), in modulating depressive-like behaviors in ovariectomy (OVX) mice.
  • To elucidate the underlying mechanisms, including inflammatory pathways, oxidative stress, and the indoleamine 2,3-dioxygenase 1 (IDO1)/tryptophan (TRP)/kynurenine (KYN) pathway.

Main Methods:

  • OVX mice were treated with E2. Behavioral tests (tail suspension test, forced swimming test) were conducted.
  • Serum E2 levels, hippocampal inflammatory mediators (NF-κB, TNF-α, IL-6), oxidative stress factors, IDO1, and neurotransmitters were measured.
  • Cell injury models (LPS or H2O2 stimulation in HT22 and BV2 cells) were used with ERβ inhibitors or siRNA to explore mechanisms.

Main Results:

  • E2 treatment significantly improved depressive-like behaviors in OVX mice.
  • E2 administration ameliorated hippocampal inflammation, oxidative stress, and modulated the IDO1-mediated TRP/KYN pathway.
  • ERβ inhibition reversed the beneficial effects of E2, indicating ERβ's crucial role.

Conclusions:

  • E2 exerts antidepressant functions in OVX mice primarily through ERβ.
  • ERβ mediates E2's effects by suppressing NF-κB-driven inflammation, oxidative stress, and the IDO1-mediated TRP/KYN pathway in the hippocampus.